PS Kineziterapija - Company finances
|
EUR
|
2024
From: 2024-08-09
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 1,020 | 4,224 |
| Profit before tax | 511 | 259 |
| Net profit | 511 | 259 |
| Equity | 511 | 780 |
| Liabilities | 508 | 766 |
| Non-current assets | 0 | 561 |
| Current assets | 1,019 | 985 |
| Total assets | 1,019 | 1,546 |
|
Taxes paid
|
||
| STI taxes | - | 137 |
|
Financial indicators
|
||
| Revenue change y/y | - | +314.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 50.1% | 16.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 33.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 50.1% | 6.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 50.1% | 6.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
PS Kineziterapija - Social security debts
The company had no debts to Sodra
PS Kineziterapija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
PS Kineziterapija, MB, company code 306969105, is a small partnership operating in physiotherapy activities. In 2025, revenue reached €4.2K, compared with €1.0K in 2024, which indicates a strong year-on-year increase of 314.1%. Net profit in 2025 was €259, down from €511 in 2024, and the net profit margin narrowed to 6.1% from 50.1%. The balance sheet remained modest in size: total assets amounted to €1.5K at the end of 2025, with equity of €780 and liabilities of €766. The equity ratio stood at 50.5%, while debt-to-equity was 0.98, pointing to a broadly balanced funding structure. ROE was 33.2% and ROA 16.8%, both reflecting the small asset base. Asset turnover was 2.73x, showing that the company generated revenue efficiently relative to assets. Overall, 2025 was characterized by rapid revenue growth, lower profitability than in 2024, and a stable capital structure.